Drug Formulary Review Archives – January 1, 2002
January 1, 2002
View Issues
-
Blockbuster sepsis drug drotrecogin alfa (activated) receives FDA approval
-
Health systems establish rigid guidelines for Xigris
-
Guidelines for drotrecogin alfa (activated) — Xigris
-
Feds revising drug discount proposal
-
News from the ASHP Midyear Clinical Meeting
-
News Briefs: FDA issues stronger warnings for droperidol
-
News Briefs: Postal workers see side effects from Cipro
-
News Briefs: Lamotrigine who?
-
Drug Criteria & Outcomes: Tinzaparin formulary evaluation: DVT treatment
-
Drug Criteria & Outcomes: In the Pipeline